Okuma and okoloba communities get issue but Na Ewu-Urhobo monarch dey say army came to protect their people while Okuama people says otherwise. May the souls of the Nigeria Army personnel who died rest in peace.

Not a good replay from a sitting governor whose responsibility is to ensure things like this never happens just like in developed climes.

Our incoming President!

Even Donald Trump talk am

chronique:
Lol. When we talk about the hypocrisy of the US, some dumb idiots will attribute it to lack/denial of visa. How do you tell the world that a certain government is bad and that people should avoid buying oil from them so as to starve them of funds from invading smaller countries, but you then go behind to increase your oil purchase from the same country? Isn't that pure hypocrisy at play? Why not stick to your principles and totally starve them of funds as you have proposed? Some morons will still come here to defend this as if their unbilical cord was shipped to America at birth. For those who think most of us that criticize America, hate the US, hear this: we don't hate the US; we simply do not subscribe to the double standards and their leaders engage in. He who comes to equity must come with clean hands.

#peterobi2023

I bought egg roll less than three weeks ago. I was shocked to see egg that was badly cut with only half inside the roll. Some people don throw conscience away

These world powers should let sleeping wars lions lie O!

cluewebhost:
When you go to the bank they'd be annoyed and tell you to open another one through one of their marketers
That was my experience.

Typical of Nigerian service provider's staff. They like to kill the joy of technological advancement

It's obvious the actors planned this stunt to increase the price of petrol by importing bad Pms to create scarcity. Let's see how this drama ends with Nigerians accepting it.

Hannafie:
If it is bank related. U can try linking your email.
I use to have this problem until I manage to realise that some of the banks send the otp to both phone and email(if linked). Maybe you should try linking your email to ur bank account. But please make sure your email password is very strong, don't use phone numbers or name. A strong password should have a mixture of upper nd lower case letters,special characters such as $%/."!/_=,e.t.c nd numbers. this is an example of a strong password #Hannafie1.0.1@20$.
I am sure of Gtbank, stanbic,access,standard chartered email Otp.
So maybe u can try this nd free ur self from yeye glo network.

Thanks for your suggestions. The issue is not for bank transactions but also from websites that requires you to KYC and this glo network is not helping matters. I wish this can be moved to front page for a lot of people facing this challenge share their experience, and GLO Mobile Network reps will see and take actions immediately

I don't know if this is the right section of Nairaland to post this topic.
For days as I have come to observed, One Time Password (OTP) gets delayed beyond the time of usage when carrying out certain transactions or to gain certain web access. Some times, this delay extends more than 6hrs to 24hrs. I should believe this may be frustrating users now, and when especially there is urgent access or transactions to resolve requiring OTP. The worst is that GLO Mobile disabled customer care number 121 option to speak to their agent to resolve this issue.

If you are experiencing same, please kindly share how best you were able to overcome this challenge from glo Mobile Network with no explanation circular to customers till now as I type.

Moderator can help to push it to the right page or possibly to front page for GLO Mobile Network staff see these complaints.

2

The southern Nigeria states should not be comfortable with this supposed tactical approach to fighting bandits. This ploy maybe extended to the South. Justification then would be ' we did it in the North, why can't we do it in the south'?.

I thought your masters said restructuring is not possible. So what is stirring this talk now?

No higher risk of blood clots in those vaccinated –Regulatory body

Denmark, Norway and Iceland on Thursday temporarily suspended the use of AstraZeneca’s Covid-19 vaccine over concerns about patients developing post-jab blood clots, as the manufacturer and Europe’s medicines watchdog insisted the vaccine was safe.

Denmark was first to announce its suspension, “following reports of serious cases of blood clots” among people who had received the vaccine, the country’s Health Authority said in a statement.


It stressed the move was precautionary, and that “it has not been determined, at the time being, that there is a link between the vaccine and the blood clots”.

However, Europe’s medicines regulator said Thursday there appeared to be no higher risk of blood clots in those vaccinated against Covid-19, after Denmark, Norway and Iceland suspended use of the AstraZeneca jab.

“The information available so far indicates that the number of thromboembolic events in vaccinated people is no higher than that seen in the general population,” the European Medicines Agency told AFP by email when asked about the suspension.


As of March 9, 22 cases of blood clots had been reported among more than three million people vaccinated in the European Economic Area, the European Medicines Agency (EMA) said.

Austria announced on Monday that it had suspended the use of a batch of AstraZeneca vaccines after a 49-year-old nurse died of “severe blood coagulation problems” days after receiving an anti-Covid shot.

Four other European countries — Estonia, Latvia, Lithuania and Luxemburg — have also suspended the use of vaccines from this batch, which was sent to 17 European countries and consisted of one million jabs.


Denmark however suspended the use of all of its AstraZeneca supply, as did Iceland and Norway in subsequent announcements on Thursday citing similar concerns.

On Wednesday, the EMA said a preliminary probe showed that the batch of AstraZeneca vaccines used in Austria was likely not to blame for the nurse’s death.

‘Super-cautious’

“This is a super-cautious approach based on some isolated reports in Europe,” said Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine.


“The risk and benefit balance is still very much in favour of the vaccine,” he said.

AstraZeneca, an Anglo-Swedish company which developed the vaccine with Oxford University, defended the safety of its product.

“The safety of the vaccine has been extensively studied in phase III clinical trials and peer-reviewed data confirms the vaccine has been generally well tolerated,” a spokesman for the group told AFP.

Britain, whose widely-praised vaccine rollout has been largely underpinned by the AstraZeneca jab, also defended it as “both safe and effective”.


The Danish suspension, which will be reviewed after two weeks, is expected to slow down the country’s vaccination campaign.

Denmark now expects to have its entire adult population vaccinated by mid-August instead of early July, the health authority said.

“We are of course saddened by this news,” said Prime Minister Mette Frederiksen.

Frederiksen, who has pushed for the production of more vaccines and has formed a controversial alliance with Austria and Israel to do so, defended the Danish health authorities’ decision.


“There is always a risk associated with vaccines,” she told reporters.

“Things have gone well in Denmark, but there are some risks linked to the AstraZeneca vaccine that need to be examined more closely. That seems to me to be the right way to proceed.”

Danish Health Authority director Soren Brostrom stressed that “we have not terminated the use of the AstraZeneca vaccine, we are just pausing its use”.


“There is broad documentation proving that the vaccine is both safe and efficient,” Brostrom said.

“But both we and the Danish Medicines Agency must act on information about possible serious side effects, both in Denmark and in other European countries.”

Denmark said one person had died after receiving the vaccine. The EMA has launched an investigation into that death.

In the Scandinavian country of 5.8 million, around 25 percent of those who have received a first dose were given the AstraZeneca jab.


In total, 3.8 percent of the population has received two doses of vaccine and 13.4 percent at least one dose.

(AFP)

https://punchng.com/denmark-norway-iceland-suspend-astrazeneca-vaccination-after-blood-clot-reports/?amp=1

The english accent used in this video do not sound like any one from the tribes of the Niger Delta region

South Africa has put its rollout of the Oxford-AstraZeneca vaccine on hold after a study showed "disappointing" results against its new Covid variant.

Scientists say the variant accounts for 90% of new Covid cases in South Africa.

The trial, involving some 2,000 people, found that the vaccine offered "minimal protection" against mild and moderate cases.

But experts are hopeful that the vaccine will still be effective at preventing severe cases.

South Africa has recorded almost 1.5 million coronavirus cases and more than 46,000 deaths since the pandemic began - a higher toll than any other country on the continent.

The country has received one million doses of the Oxford-AstraZeneca jab and was preparing to start vaccinating people.

Source: https://www.bbc.com/news/world-africa-55975052

Oxford jab offers less S Africa Covid protection
How worrying are the new variants?
South Africa coronavirus variant: What's the risk?
On Monday, the World Health Organization (WHO) warned against jumping to conclusions about the efficacy of Covid vaccines.

Dr Katherine O'Brien, the WHO's director of immunisation, said it was very plausible that the Oxford-AstraZeneca vaccine would still have a meaningful impact on the South African variant, especially when it came to preventing hospitalisations and death.

"Comparing from one piece of evidence to the next really can't be done without a sort of level playing field," she said, referring to the evaluation of different trials in different populations and age groups.

Dr O'Brien stressed that the WHO's expert panel held "a very positive view" of proceeding with the use of the vaccine, including in areas where variants were circulating, but that more data and information would be needed as the pandemic continued.

South Africa's Health Minister Zweli Mkhize said his government would wait for further advice on how best to proceed with the AstraZeneca vaccine in light of the findings.

In the meantime, he said, the government would offer vaccines produced by Johnson & Johnson and Pfizer in the coming weeks.

What does it mean for serious cases?
The trial was carried out by researchers at the University of the Witwatersrand in South Africa and the UK's Oxford University, but has not yet been peer reviewed.

The trial's chief investigator, Prof Shabir Madhi, said it showed that "unfortunately, the AstraZeneca vaccine does not work against mild and moderate illness".


media captionProf Barry Schoub on South Africa's decision to stop the AstraZeneca vaccine roll-out.
Prof Madhi said the study had not been able to investigate the vaccine's efficacy in preventing more serious infections, as participants had an average age of 31 and so did not represent the demographic most at risk of severe symptoms from the virus.

The vaccine's similarity to one produced by Johnson & Johnson, which was found in a recent study to be highly effective at preventing severe disease in South Africa, suggested it would still prevent serious illness, according to Prof Madhi.

"There's still some hope that the AstraZeneca vaccine might well perform as well as the Johnson & Johnson vaccine in a different age group demographic that I address of severe disease," he told the BBC.

Other experts were also hopeful that the vaccine remained effective at combating more serious cases.

"What we're seeing from other vaccine developers is that they have a reduction in efficacy against some of the variant viruses and what that is looking like is that we may not be reducing the total number of cases, but there's still protection in that case against deaths, hospitalisations and severe disease," Prof Sarah Gilbert, Oxford's lead vaccine developer, told the Andrew Marr Show on Sunday.

She said developers were likely to have a modified version of the injection against the South Africa variant, also known as 501.V2 or B.1.351, later this year.

Ministers in the UK have sought to reassure the public over the effectiveness of the Oxford-AstraZeneca vaccine. Vaccines Minister Nadhim Zahawi said the injection appeared to work well against dominant variants in the UK, while Health Minister Edward Argar said there was "no evidence" the vaccine was not effective at preventing severe illness.

Wow! What a great revelation

softset:
The end of an era. Good riddance.

The beginning of a new government begins tomorrow. I wish President Joe Biden and his team great success as they take America to the next level.

God bless America.

Ha! APC Next level?

Those '1923 Badagary Merry Xmas' letters were not painted on the body of the black slaves but photoshopped.

Old layer here is #2000